Literature DB >> 19341415

Liver and intestine transplantation in the United States 1998-2007.

C L Berg1, D E Steffick, E B Edwards, J K Heimbach, J C Magee, W K Washburn, G V Mazariegos.   

Abstract

Liver transplantation numbers in the United States remained constant from 2004 to 2007, while the number of waiting list candidates has trended down. In 2007, the waiting list was at its smallest since 1999, with adults > or =50 years representing the majority of candidates. Noncholestatic cirrhosis was most commonly diagnosed. Most age groups had decreased waiting list death rates; however, children <1 year had the highest death rate. Use of liver allografts from donation after cardiac death (DCD) donors increased in 2007. Model for end-stage liver disease (MELD)/pediatric model for end-stage liver disease (PELD) scores have changed very little since 2002, with MELD/PELD <15 accounting for 75% of the waiting list. Over the same period, the number of transplants for MELD/PELD <15 decreased from 16.4% to 9.8%. Hepatocellular carcinoma exceptions increased slightly. The intestine transplantation waiting list decreased from 2006, with the majority of candidates being children <5 years old. Death rates improved, but remain unacceptably high. Policy changes have been implemented to improve allocation and recovery of intestine grafts to positively impact mortality. In addition to evaluating trends in liver and intestine transplantation, we review in depth, issues related to organ acceptance rates, DCD, living donor transplantation and MELD/PELD exceptions.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19341415     DOI: 10.1111/j.1600-6143.2009.02567.x

Source DB:  PubMed          Journal:  Am J Transplant        ISSN: 1600-6135            Impact factor:   8.086


  38 in total

1.  Exfoliative rejection in intestinal transplantation.

Authors:  K T Park; William L Berquist; Reetesh Pai; George Triadafilopoulos
Journal:  Dig Dis Sci       Date:  2010-08-04       Impact factor: 3.199

2.  Pediatric Liver Transplantation: Our Experiences.

Authors:  Ahmet Basturk; Aygen Yılmaz; Ersin Sayar; Ayhan Dinçkan; İbrahim Aliosmanoğlu; Halil Erbiş; Bülent Aydınlı; Reha Artan
Journal:  Eurasian J Med       Date:  2016-10

3.  Racial and Ethnic Differences in Graft Loss Among Female Liver Transplant Recipients.

Authors:  S Dave; J L Dodge; N A Terrault; M Sarkar
Journal:  Transplant Proc       Date:  2018-06       Impact factor: 1.066

4.  Impact of MELD-based allocation on end-stage renal disease after liver transplantation.

Authors:  P Sharma; D E Schaubel; M K Guidinger; N P Goodrich; A O Ojo; R M Merion
Journal:  Am J Transplant       Date:  2011-08-22       Impact factor: 8.086

5.  Age is not a contraindication for orthotopic liver transplantation: a single institution experience with recipients older than 75 years.

Authors:  C Burcin Taner; Ryan L Ung; Barry G Rosser; Jaime Aranda-Michel
Journal:  Hepatol Int       Date:  2011-06-18       Impact factor: 6.047

Review 6.  Gender-based disparities in access to and outcomes of liver transplantation.

Authors:  Omobonike O Oloruntoba; Cynthia A Moylan
Journal:  World J Hepatol       Date:  2015-03-27

Review 7.  Short bowel syndrome in the NICU.

Authors:  Sachin C Amin; Cleo Pappas; Hari Iyengar; Akhil Maheshwari
Journal:  Clin Perinatol       Date:  2013-01-17       Impact factor: 3.430

Review 8.  Liver Transplantation for Alcohol-Related Liver Disease.

Authors:  Narendra S Choudhary; Naveen Kumar; Sanjiv Saigal; Rahul Rai; Neeraj Saraf; Arvinder S Soin
Journal:  J Clin Exp Hepatol       Date:  2016-02-27

9.  Is liver transplantation safe and effective in elderly (≥70 years) recipients? A case-controlled analysis.

Authors:  Gregory C Wilson; R Cutler Quillin; Koffi Wima; Jeffrey M Sutton; Richard S Hoehn; Dennis J Hanseman; Ian M Paquette; Flavio Paterno; E Steve Woodle; Daniel E Abbott; Shimul A Shah
Journal:  HPB (Oxford)       Date:  2014-08-06       Impact factor: 3.647

10.  Old and rising stars in the lymphoid liver.

Authors:  Carlo Selmi; Mauro Podda; M Eric Gershwin
Journal:  Semin Immunopathol       Date:  2009-07-15       Impact factor: 9.623

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.